Intrepida Bio
About:
IntrepidaBio is a preclinical biotechnology company.
Website: https://intrepidabio.com/
Top Investors: Sofinnova Investments, Canaan Partners, Vertis, Indaco Venture Partners
Description:
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity.
Total Funding Amount:
$9.5M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
San Diego, California, United States
Founded Date:
2019-01-01
Founders:
Joel F. Martin, Olivier Laurent
Number of Employees:
1-10
Last Funding Date:
2019-10-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai